Indefinite Delivery Contract SPE2DX15D9516

The federal contract IDV award SPE2DX15D9516 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The provided task orders, valued at $29,884, $25,226.20, and $324, represent firm fixed-price delivery orders issued under the IDC to support the Prime Vendor Pharmaceutical Branch-Philadelphia's recurring pharmaceutical and medical supply requirements. These task orders were awarded with no set-asides and performed at DMS Pharmaceutical Group's facility in Park Ridge, Illinois. The IDC and associated delivery orders position DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.